Ketamine normalizes hyperactivity in key brain region of depressed patients
There is no shortage of psychological and pharmacological therapies to combat the world’s most widespread mental health issue, major depressive disorder (MDD). However, a significant portion of the affected population fail to respond to many of these traditional therapies. For this reason, new drugs must be tested and validated. One promising candidate is ketamine – famously but somewhat improperly known as a horse tranquilizer.
No comments:
Post a Comment